ALRN - Aileron Therapeutics GAAP EPS of -$0.09 misses by $0.01 May, 05 2022 05:15 PM Aileron Therapeutics Inc. Aileron Therapeutics press release (NASDAQ:ALRN): Q1 GAAP EPS of -$0.09 misses by $0.01. Cash and cash equivalents of $38.07M For further details see: Aileron Therapeutics GAAP EPS of -$0.09 misses by $0.01